References to Bcl-2 (Apoptosis regulator Bcl 2)
- Dalla Palma P, Doglioni C, Pezzella F, Eccher C, Morelli L, Girlando S, Bonzanini M, Fox S, Fina P, Leek RD, Veronese S, Caffo O, Barbareschi M, Harris A. Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up. Hum Pathol. 1996 Nov;27 (11):1149-55
- Gabbert HE, Willers R, Dutkowski P, Verreet P, Porschen R, Bittinger F, Sarbia M. bcl-2 expression and prognosis in squamous-cell carcinomas of the esophagus. Int J Cancer. 1996 Aug 22;69 (4):324-8
- Kitada S, Bodrug S, Aime-Sempe C, Krajewski S, Sato T, Wang HG, Takayama S, Miyashita T, Reed JC, Hanada M. BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem. 1996 Jan;60 (1):23-32
- Hockenbery DM, Park JR. BCL-2, a novel regulator of apoptosis. J Cell Biochem. 1996 Jan;60 (1):12-7
- Lalani EN, Foster CS, Abel P, Lu QL. bcl-2: role in epithelial differentiation and oncogenesis. Hum Pathol. 1996 Feb;27 (2):102-10
- Kaushansky K, Yee E, Karsan A, Harlan JM. Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. Blood. 1996 Apr 15;87 (8):3089-96
- Su IJ, Jin YT, Yan JJ, Chen FF. Detection of bcl-2 and p53 in thymoma: expression of bcl-2 as a reliable marker of tumor aggressiveness. Hum Pathol. 1996 Oct;27 (10):1089-92
- Boccadoro M, Bianchi A, Montacchini L, Beggiato E, Barral P, Attisano C, Borrione P, Massaia M, Pileri A. Dysregulated Fas and Bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients. Blood. 1995 Jun 15;85 (12):3679-87
- Savchenko V, Goodacre A, Munker R, Snell V, Sanchez-Williams G, Consoli U, Zhang X, Estrov Z, Lisovsky M, Andreeff M. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax. Blood. 1996 Nov 15;88 (10):3987-97
- Cohen IR, Mor F. IL-2 rescues antigen-specific T cells from radiation or dexamethasone-induced apoptosis. Correlation with induction of Bcl-2. J Immunol. 1996 Jan 15;156 (2):515-22
- Vaughan Hudson G, Anderson L, Di Stefano F, Clarke P, Burke M, Vaughan Hudson B, Cunningham DC, MacLennan KA, Hill ME, Mason D, Selby P, Linch DC. Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study. Blood. 1996 Aug 1;88 (3):1046-51
- Miyazaki K, Tokunaga O, Sasatomi E. Spontaneous apoptosis in gallbladder carcinoma. Relationships with clinicopathologic factors, expression of E-cadherin, bcl-2 protooncogene, and p53 oncosuppressor gene. Cancer. 1996 Nov 15;78 (10):2101-10
Shopping cart
Your cart is empty.